Thoughts on $BAX and AI integration outlook

Considering Baxter's recent uptick to $20.795, a 3.46% jump, and their ongoing efforts to integrate AI into medical device diagnostics, I'd put the odds of them announcing a significant partnership or new AI-driven product line within Q3 at about 60%. It seems like a natural progression given current market trends and their prior statements on digital health.